RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Most relevant regions
Press
Sep 11, 2007
Many seniors quit taking drugs for chronic illnesses such as diabetes and high blood pressure when they exceed their drug plan's yearly spending limits.
Research Summary
This fact sheet summarizes a systematic review of published studies to analyze how the cost-sharing features of prescription drug benefits may affect access to prescription drugs and, consequently, health outcomes.
This research brief examines the likely effects of the gap in the Medicare Part D standard drug benefit after $2,400 in pharmaceutical spending, using data from a private employer.
Jul 26, 2007
RAND Presents First Victor R. Fuchs Research Award to Team of Economists from Carnegie Mellon University.
Research
Apr 1, 2007
The authors hypothesize that DM improves adherence to prescriptions more than the rate with which prescriptions are being filled.
Jan 1, 2007
In this paper the authors examine medication use among retirees with employer-sponsored drug coverage both with and without annual benefit limits.
Clinicians find it difficult to know which drugs are covered for their Medicare patients because formularies vary widely among Medicare Part D plans
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly.
Prescription drugs are instrumental to managing and preventing chronic disease.
Commentary
Jan 13, 2006
The federal government's new Medicare prescription-drug benefit program for the elderly and disabled, which went into effect Jan. 1, has gotten off to a slow start, writes Geoffrey Joyce.
Jan 12, 2006
This Research Brief summarizes the relationship between (1) co-payments and compliance for patients whose doctors prescribed cholesterol-lowering drugs, and (2) compliance and subsequent use of expensive health care services.
Jan 1, 2006
Varying copayments for CL therapy by therapeutic need would reduce hospitalizations and ED use--with total savings of more than $1 billion annually.